Cell Line News and Research

RSS
Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

New alpha-radioimmunotherapy for multiple myeloma shows promise in preclinical study

New alpha-radioimmunotherapy for multiple myeloma shows promise in preclinical study

New research project receives federal funding to expand treatment options for sickle cell patients

New research project receives federal funding to expand treatment options for sickle cell patients

Horizon Discovery introduces single cell RNAseq-linked CRISPR screening service

Horizon Discovery introduces single cell RNAseq-linked CRISPR screening service

Investigational drug shows promising results for treating HNSCC tumors

Investigational drug shows promising results for treating HNSCC tumors

Study suggests new approach to make radiation therapy more effective for glioblastoma patients

Study suggests new approach to make radiation therapy more effective for glioblastoma patients

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Study identifies phosphorylation-based biomarkers to guide cancer therapy

Study identifies phosphorylation-based biomarkers to guide cancer therapy

New strategy may help guard beta cells, slow the onset of type 1 diabetes

New strategy may help guard beta cells, slow the onset of type 1 diabetes

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Study shows fused lung cells are pervasive in severe COVID-19

Study shows fused lung cells are pervasive in severe COVID-19

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

CNIO’s collaborative platform simplifies research on brain metastasis

CNIO’s collaborative platform simplifies research on brain metastasis

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows